Treatment of both glioblastoma cell lines9 and renal cell carcinoma cell line (UOK146)19 with histone deacetylase inhibitors also result in a significant increase in DIRAS1 mRNA levels. This evidence concerns the gene DIRAS1 and glioblastoma.